4.5 Article

Effect of Lipophilicity on Microneedle-Mediated Iontophoretic Transdermal Delivery Across Human Skin In Vitro

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 102, 期 10, 页码 3784-3791

出版社

ELSEVIER SCIENCE INC
DOI: 10.1002/jps.23694

关键词

iontophoresis; skin; diffusion; percutaneous; transdermal drug delivery

资金

  1. NSF [1137682]
  2. Direct For Education and Human Resources
  3. Division Of Human Resource Development [1137682] Funding Source: National Science Foundation

向作者/读者索取更多资源

The effect of lipophilicity of drug on the microneedle (MN)-mediated iontophoretic delivery across dermatomed human skin was studied. Beta blockers with similar pK(a) but varied logP values were selected as model drugs in this study. Iontophoresis (ITP) or MNs, when used independently, increased the transdermal flux of beta blockers as compared with passive delivery (PD). ITP across the MN-treated skin (MN+ITP) increased the permeation rate of all beta blockers as compared with PD (p<0.001). The enhancement ratios (ER) for hydrophilic molecules (atenolol and sotalol) were 71- and 78-fold higher for ITP+MN as compared with PD. However, for lipophilic molecule such as propranolol, there was 10-fold increase in the ER as compared with PD. These observations were further substantiated by the skin retention data; an inverse relationship between the skin retention and the hydrophilicity of the drug was observed. The results in the present study point out that the lipophilicity of the molecule plays a significant role on the electrically assisted transdermal delivery of drugs across the microporated skin. Using the combination of ITP+MN, hydrophilic drugs (atenolol and sotalol) were delivered at a much higher rate as compared with lipophilic molecules (propranolol and acebutolol). (c) 2013 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 102:3784-3791, 2013

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines

Li Chen, Hamad Alrbyawi, Ishwor Poudel, Robert D. Arnold, R. Jayachandra Babu

AAPS PHARMSCITECH (2019)

Article Biochemical Research Methods

Stability-indicating HPLC method for acyclovir and lidocaine in topical formulations

Vanisree Mulabagal, Manjusha Annaji, Sharmila Kurapati, Ranjeet Prasad Dash, Nuggehally R. Srinivas, Amit K. Tiwari, R. Jayachandra Babu

BIOMEDICAL CHROMATOGRAPHY (2020)

Article Pharmacology & Pharmacy

pH-Sensitive Liposomes for Enhanced Cellular Uptake and Cytotoxicity of Daunorubicin in Melanoma (B16-BL6) Cell Lines

Hamad Alrbyawi, Ishwor Poudel, Manjusha Annaji, Sai H. S. Boddu, Robert D. Arnold, Amit K. Tiwari, R. Jayachandra Babu

Summary: In this study, a pH-sensitive liposomal system was used to deliver daunorubicin to melanoma cells, resulting in enhanced cytotoxic effects. The liposomes exhibited high drug encapsulation efficiency and rapid release at acidic pH, leading to significantly higher cytotoxicity compared to conventional daunorubicin or liposomes.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Cardiolipin for Enhanced Cellular Uptake and Cytotoxicity of Thermosensitive Liposome-Encapsulated Daunorubicin toward Breast Cancer Cell Lines

Hamad Alrbyawi, Sai H. S. Boddu, Ishwor Poudel, Manjusha Annaji, Nur Mita, Robert D. Arnold, Amit K. Tiwari, R. Jayachandra Babu

Summary: This study developed a co-delivery system of daunorubicin and cardiolipin encapsulated in thermosensitive liposomes for the treatment of breast cancer. The liposomes exhibited high drug encapsulation efficiency, small size, and rapid release under mild hyperthermia, resulting in significantly higher cytotoxicity against breast cancer cells compared to daunorubicin or conventional liposomes. This research lays the foundation for future development of liposomal co-delivery systems for breast cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Biochemistry & Molecular Biology

Lysinated Multiwalled Carbon Nanotubes with Carbohydrate Ligands as an Effective Nanocarrier for Targeted Doxorubicin Delivery to Breast Cancer Cells

Chanchal Kiran Thakur, Rabin Neupane, Chandrabose Karthikeyan, Charles R. Ashby, R. Jayachandra Babu, Sai H. S. Boddu, Amit K. Tiwari, Narayana Subbiah Hari Narayana Moorthy

Summary: A simple and cost-effective method was reported to functionalize MWCNTs with carbohydrate ligands using lysine as a linker. The results showed that carbohydrate-modified MWCNTs had higher drug loading capacity and improved anticancer efficacy.

MOLECULES (2022)

Article Pharmacology & Pharmacy

Enhanced Topical Co-delivery of Acyclovir and Lidocaine Gel Formulation Across Dermatomed Human Skin

Manjusha Annaji, Nur Mita, Shivani Rangari, Mohammed F. Aldawsari, Ahmed Alsaqr, Ishwor Poudel, Oladiran Fasina, R. Jayachandra Babu

Summary: In this study, a topical gel formulation containing acyclovir and lidocaine was tested for its skin permeation properties. The results showed that the gel had significantly higher transdermal flux and skin retention compared to commercial formulations. It also showed increased permeation across microporated skin.

AAPS PHARMSCITECH (2022)

Article Biochemistry & Molecular Biology

Hispolon Cyclodextrin Complexes and Their Inclusion in Liposomes for Enhanced Delivery in Melanoma Cell Lines

Ishwor Poudel, Manjusha Annaji, Fajar Setyo Wibowo, Robert D. Arnold, Oladiran Fasina, Brian Via, Vijaya Rangari, Maria Soledad Peresin, Forrest Smith, Muralikrishnan Dhanasekaran, Amit K. Tiwari, R. Jayachandra Babu

Summary: This study investigates the preparation of an inclusion complex of Hispolon with Sulfobutylether-beta-cyclodextrin (SBE beta CD) and the formulation of Hispolon-SBE beta CD trapped within sterically stabilized liposomes (HSC-SL). The results show that HSC-SL exhibits enhanced anticancer activity against melanoma cell lines and sustained drug release compared to Hispolon liposomes and Hispolon-SBE beta CD liposomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

Microwave-Assisted Functionalization of Multi-Walled Carbon Nanotubes for Biosensor and Drug Delivery Applications

Chanchal Kiran Thakur, Chandrabose Karthikeyan, Mariam Sami Abou-Dahech, Moawia Mohd A. M. Altabakha, Moayad Jamal Saeed Al Shahwan, Charles R. R. Ashby Jr, Amit K. Tiwari, R. Jayachandra Babu, Narayana Subbiah Hari Narayana Moorthy

Summary: Microwave-assisted synthetic methods are commonly used for the surface modification and functionalization of multi-walled carbon nanotubes (MWCNTs) in diverse drug delivery applications. Microwave-induced functionalization of MWCNTs offers high efficiency and shorter reaction time compared to conventional techniques. Microwave methods are simple, fast, and effective for the covalent and noncovalent conjugation of MWCNTs with various biomolecules and polymers. This review focuses on the synthesis and drug delivery applications of microwave irradiation techniques (MITs) for the functionalization of MWCNTs using amino acids, vitamins, proteins, epoxy moieties, metal nanoparticles, and polymers.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Topical Delivery of Diacetyl Boldine in a Microemulsion Formulation for Chemoprotection against Melanoma

Ahmed Al Saqr, Manjusha Annaji, Ishwor Poudel, Mohammed F. Aldawsari, Hamad Alrbyawi, Nur Mita, Muralikrishnan Dhanasekaran, Sai H. S. Boddu, Rabin Neupane, Amit K. Tiwari, R. Jayachandra Babu

Summary: This study aimed to develop a microemulsion formulation for topical delivery of Diacetyl Boldine (DAB) and evaluate its cytotoxicity against melanoma cell line (B16BL6) in vitro. The results showed that the microemulsion formulation exhibited significantly higher skin retention levels than the DAB solution in MCT oil. Additionally, the microemulsion formulations showed substantially higher cytotoxicity toward B16BL6 cell lines than the control formulation.

PHARMACEUTICS (2023)

Review Pharmacology & Pharmacy

Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

Xuejia Kang, Sanika Jadhav, Manjusha Annaji, Chung-Hui Huang, Rajesh Amin, Jianzhong Shen, Charles R. R. Ashby Jr, Amit K. K. Tiwari, R. Jayachandra Babu, Pengyu Chen

Summary: Disulfiram (DSF) is an approved drug for alcoholism treatment and has shown anticancer efficacy in preclinical studies. Supplementing DSF with copper (CuII) enhances its efficacy. However, clinical trials have not yielded promising results. Understanding the anticancer mechanisms of DSF/Cu (II) may lead to repurposing DSF as a new cancer treatment.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Liposomal DQ in Combination with Copper Inhibits ARID1A Mutant Ovarian Cancer Growth

Xuejia Kang, Qi Wang, Siqi Wu, Chuanyu Wang, Manjusha Annaji, Chung-Hui Huang, Jianzhong Shen, Pengyu Chen, R. Jayachandra Babu

Summary: Therapeutic strategies for ARID1A-mutant ovarian cancers are limited. Higher basal ROS and lower basal GSH enhance the aggressive proliferation ability and metastatic property of OCCCs through EMT induction and immunosuppressive microenvironment. However, the aberrant redox homeostasis also increases the sensitivity of DQ-Lipo/Cu in mutant cells. DQ generates DDC in response to ROS, which together with Cu generates ROS cascade and targets GSH vulnerability, disrupting redox homeostasis and causing cancer cell death. The formed Cu(DDC)2 acts as a potent cytotoxic anti-cancer drug inducing immunogenic cell death, providing a promising strategy for managing cancer metastasis and drug resistance.

BIOMOLECULES (2023)

Review Chemistry, Medicinal

Exploring the Application of Micellar Drug Delivery Systems in Cancer Nanomedicine

Qi Wang, Keerthi Atluri, Amit K. Tiwari, R. Jayachandra Babu

Summary: Various formulations of polymeric micelles are being investigated as potential nanomedicines for cancer treatment. They target specific tissues and have prolonged circulation in the body. This review focuses on the different polymeric materials available for micelle synthesis and the ways they can be tailored to be responsive to different stimuli. It also discusses clinical trends, drug delivery applications, and challenges in this field.

PHARMACEUTICALS (2023)

Review Oncology

Clinical outcomes of chemotherapy in cancer patients with different ethnicities

Suhrud Pathak, Kelsee K. Zajac, Manjusha Annaji, Manoj Govindarajulu, Rishi M. Nadar, Dylan Bowen, R. Jayachandra Babu, Muralikrishnan Dhanasekaran

Summary: Choosing the most effective and least toxic chemotherapy drug is a challenge in cancer treatment. The individual's genetic makeup plays a significant role in drug response, and personalized medication regimens based on pharmacogenomics can optimize treatment outcomes. However, current standardized chemotherapy protocols rarely consider these individual differences. Therefore, integrating personalized medicine with clinical data of different ethnicities can improve treatment outcomes for patients of different ethnic backgrounds.

CANCER REPORTS (2023)

Article Medicine, Research & Experimental

Gentamicin Eluting 3D-Printed Implants for Preventing Post-Surgical Infections in Bone Fractures

Ishwor Poudel, Manjusha Annaji, Chu Zhang, Peter R. Panizzi, Robert D. Arnold, Amal Kaddoumi, Rajesh H. Amin, Seungjong Lee, Nima Shamsaei, R. Jayachandra Babu

Summary: A surgically implantable device is a necessary treatment option for millions worldwide with orthopedic injuries. The use of additive manufacturing has enabled the customized fabrication of orthopedic implants with surface modifications. This study investigates the application of laser powder bed fusion to create 3D-printed implants functionalized with antimicrobial coatings to treat postsurgical infections.

MOLECULAR PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Oral and dermal toxicity of alkenones extracted from Isochrysis species

Kyle McIntosh, Jeffrey Sarver, Kristopher Mell, David J. Terrero, Charles R. Ashby, Chris Reddy, Gregory O' Neil, Jayachandra Babu Ramapuram, Amit K. Tiwari

FRONTIERS IN BIOSCIENCE-LANDMARK (2020)

暂无数据